logo fca transparente

Select your language

rsz logo unicamp

The Internal Biosafety Commission (CIBio) of FCA was created by Ordinance FCA/DIR-53/2013 on August 14, 2013 and is responsible for approving the use of Genetic Engineering techniques and methods and carrying out research with Genetically Modified Organisms (GMO) and their derivatives. On April 17, 2014 it was published in the D.O.U. the Biosafety Quality Certificate number (CQB) granted to FCA by the National Biosafety Technical Commission (CTNBio).

According to the National Biosafety Law, any researcher wishing to work with GMOs must receive prior authorization from CIBio (type I GMOs) or CTNBio (type II GMOs). The granting of this authorization involves analysis of qualification of the researcher, his research group and the adequacy of the facilities where the work with GMOs will be developed.

Even if the researcher has already received authorization to develop a given project, each new research project involving GMOs or changes in the already approved project (team, objective, inclusion of GMOs, etc.) must be submitted to CIBio in order to obtain a new authorization. To obtain authorization to work with Type I GMOs, the researcher in charge must submit the following documentation for analysis by CIBio:

CIBio's assessment will be centered on analyzing the qualifications and experience of the personnel involved in the proposed activities, in order to guarantee biosafety.


The procedure for authorizing research projects with GMOs can be checked at this link.

Legislation

Forms